Tom Forman Email & Phone Number

Indianapolis, Indiana

Portfolio leader for early phase Development in Obesity, Diabetes, and Diabetic Complications. Led the management of early phase portfolio decision making, communication strategies with senior leadership, and mentored Project Leaders.

Indianapolis, Indiana Area

Strategic leader of early phase development programs in oncology, diabetes, and obesity. Developed the overall plan for Phase 1 and 2 by leading a cross functional team of experts. Led and managed efforts on governance, communication, and decision making for several individual projects.

Director over a group of Project Managers supporting all aspects of CMC work supporting the Diabetes Business Unit. Responsibilities of the team range from start of Drug Substance manufacturing through delivery of finished goods to clinical sites. Support technical transfer from development to commercial manufacture across the CMC value chain. A key aspect is developing relationships with leadership across the drug development value chain. Other responsibilities include the management of the project management team, development of portfolio support plan for business unit, business plan development and forecasting, and communication with senior management.

Indianapolis, Indiana Area

Leader of CMC teams in the creation and implementation of integrated CMC plans for the development and commercialization of bio-molecules. Obtaining alignment within teams, across functions, affiliates, partners and customers regarding strategies and plans is essential. Other objectives that I find essential include addressing issues, communicating within and across teams and functions, providing leadership, driving decision-making, sharing learning, and participating in process improvement activities within CMC PM and the CMC functions. These objectives are accomplished by utilization of key project management tools and techniques such as; development and management of the project scope, use of critical chain methodology, budget management, and development of a risk management plan including mitigation strategies and contingency plans.In this role I led the team through the development of dulaglutide, a novel biopharmaceutical product. Work included integration of the clinical plan, regulatory plan, and product development. I led the team through the submission of a BLA to the US FDA, which included a detailed risk assessment of Human Factors studies associated with a new delivery device system.

Indianapolis, Indiana Area

In this role, I was accountable for the delivery of the commercial API process for the launch of Forteo®. My role involved the coordination of the final technical aspects from development, smooth transition into the manufacturing facility, and support for the NDA submission and subsequent PAI inspection.

Indianapolis, Indiana Area

Indianapolis, Indiana Area

Initial investor and co-owner of fine dinning restaurant in downtown Indianapolis. For this business, I developed the Business Plan and worked with investors to establish the initial operations plan. For the ongoing operations, I routinely review the business profile against the plan, and help set the strategy for future growth.

Master Of Business Administration (Mba)

After completion of an Executive Certificate in the Business of Life Sciences, I choose to complete a full MBA. For elective courses, I.

Bsche, Chemical Engineering